A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

This study will evaluate the efficacy and safety of ALKS 5461.

Phase 3

Alkermes, Inc.